| Financial Year |
March 31 2023 |
| Monetary Funds |
2,592,593,275.28 |
| Held-for-trading Financial Assets |
490,239,083.21 |
| Notes Receivable |
11,659,714.67 |
| Accounts Receivable |
1,295,502,563.83 |
| Advances to Suppliers |
180,154,277.87 |
| Other Receivables |
104,068,034.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,524,471,780.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
178,072,206.54 |
| Total Current Assets |
12,397,137,528.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,358,965.69 |
| Long-term Equity Investment |
940,382,045.29 |
| Investment Properties |
-- |
| Fixed Assetes |
2,176,964,616.45 |
| Under-construction Projects |
154,524,235.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
505,322,875.57 |
| R&D expenses |
50,942,632.32 |
| Goodwill |
2,319,632,451.37 |
| Long-Term Deferred and Prepaid Expenses |
194,023,791.43 |
| Deferred Income Tax Assets |
143,979,171.30 |
| Other Non-Current Assets |
145,857,642.96 |
| Sub-Total of Non-Current Assets |
8,225,885,203.12 |
| Total Assets |
20,623,022,731.91 |
| Short-Term Loans |
2,768,481,605.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,621,846.30 |
| Accounts Payable |
383,053,240.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
166,841,499.16 |
| Taxes Payable |
85,508,331.67 |
| Interest Payable |
-- |
| Dividend Payable |
31,808,587.27 |
| Other payables |
360,937,721.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
943,660,143.51 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
5,134,399,895.10 |
| Long-term Loans |
2,006,498,819.62 |
| Bonds Payable |
496,886,328.64 |
| Long-Term Accounts Payable |
367,765.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,452,982.78 |
| Deferred Income Tax Liabilities |
315,141,285.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,016,772,193.42 |
| Total Liabilities |
8,151,172,088.52 |
| Paid-In Capital(Or Share Stock) |
1,467,296,204.00 |
| Capital Surplus |
5,859,141,233.53 |
| Surplus Reserve |
545,376,458.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,382,473,713.38 |
| Minority Stockholder's Interest |
96,094,305.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,375,756,337.62 |
| Owner's Equity（Stockholder's Equity） |
12,471,850,643.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,623,022,731.91 |
